Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Point Capital Inc (PTCI)

Point Capital Inc (PTCI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 28.06
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.3500 +57.14%
on 07/16/19
0.5500 unch
on 07/16/19
+0.1500 (+37.50%)
since 06/07/19
3-Month
0.3500 +57.14%
on 07/16/19
0.5500 unch
on 07/16/19
+0.1500 (+37.50%)
since 03/25/19

Most Recent Stories

More News
Innocoll Holdings Limited Announces FDA Acceptance of New Drug Application for XARACOLL® for the Management of Postsurgical Pain after Open Inguinal Hernia Surgery

Innocoll Holdings Limited, a specialty pharmaceutical company and portfolio business of Gurnet Point Capital, today announced that the U.S. Food and Drug Administration (FDA) has accepted its New Drug...

PTCI : 0.5500 (+37.50%)
Craig Stapleton of Stone Point Capital Interview with Host Matt Bird at Greenwich Economic Forum - Traders Network Show; Equities News

Video Archives Now Available: Craig Stapleton, Senior Advisor, Stone Point Capital one-on-one interview with host Matt Bird at the Greenwich Economic Forum.

PTCI : 0.5500 (+37.50%)
Innocoll Holdings Limited Resubmits New Drug Application to FDA for XARACOLL® for the Management of Postsurgical Pain after Open Inguinal Hernia Surgery

Innocoll Holdings Limited, a specialty pharmaceutical company and portfolio business of Gurnet Point Capital, announced today that it has resubmitted the New Drug Application (NDA) to the U.S. Food and...

PTCI : 0.5500 (+37.50%)
Gurnet Point Capital Names David Moore Partner

Gurnet Point Capital ("Gurnet Point"), a private investment firm focused on health care, announced today that David Moore has been appointed as a Partner of the firm. Mr. Moore, who brings a proven track...

PTCI : 0.5500 (+37.50%)
Alladapt Immunotherapeutics Secures $60 Million in Series C Financing for Development of Food Allergy Therapeutics

â?' Proceeds to support clinical advancement of ADP101, a broad-spectrum oral biopharmaceutical candidate targeting food allergy â?'

PTCI : 0.5500 (+37.50%)
Safe-Guard Expands Sales Leadership Team To Further Strengthen Commitment To Client Service And Innovation

Safe-Guard Products International, LLC the leading provider of third-party private label protection products for the automotive, RV, marine and powersports industries, today announced several additions...

PTCI : 0.5500 (+37.50%)
Prescience Point Capital Management Issues Negative Research Report on Medallia, Inc. (NYSE: MDLA)

Prescience Point Capital Management ("Prescience Point"), a private investment manager that focuses on deep investigations of public companies, today published a critical research report supporting its...

PTCI : 0.5500 (+37.50%)
MDLA : 16.83 (-2.43%)
Balance Point Capital Announces its Investment in Bear Down Brands LLC

Balance Point Capital ("Balance Point"), in conjunction with its affiliated funds, Balance Point Capital Partners II, L.P. and Balance Point Capital Partners III, L.P., is pleased to announce its investment...

PTCI : 0.5500 (+37.50%)
Cerebral Therapeutics Completes $35 Million Series B Financing

Cerebral Therapeutics, a clinical-stage pharmaceutical company developing innovative treatments for uncontrolled neurological diseases, announced today a $35 million Series B financing led by RA Capital...

PTCI : 0.5500 (+37.50%)
Gregory Shewchuk Named CEO of Before Brands, a Specialist in Early Childhood Food Allergy Prevention

Before Brands, the inventor of SpoonfulOne(TM) and a science-based consumer products company dedicated to bringing innovative, proprietary nutritional products directly to families, announced today that...

PTCI : 0.5500 (+37.50%)
Trade PTCI with:

Key Turning Points

2nd Resistance Point 0.6833
1st Resistance Point 0.6167
Last Price 0.5500
1st Support Level 0.4167
2nd Support Level 0.2833

See More

52-Week High 1.0000
Fibonacci 61.8% 0.7039
Fibonacci 50% 0.6125
Last Price 0.5500
Fibonacci 38.2% 0.5210
52-Week Low 0.2250

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar